Two initial vaccinations with the Bm86-based Gavacplus vaccine against Rhipicephalus (Boophilus) microplusinduce similar reproductive suppression to three initial vaccinations under production conditions
© Vargas et al; licensee BioMed Central Ltd. 2010
Received: 14 May 2009
Accepted: 16 September 2010
Published: 16 September 2010
The cattle tick, Rhipicephalus (Boophilus) microplus, affects livestock production in many regions of the world. Up to now, the widespread use of chemical acaricides has led to the selection of acaricide-resistant ticks and to environmental contamination. Gavacplus is a subunit vaccine based on the recombinant Bm86 tick antigen expressed in yeast, capable to control infestations of R. microplus under controlled and production conditions. The vaccine constitutes the core element of broad control programs against this ectoparasite, in which acquired immunity in cattle to Bm86 is combined with a rational use of acaricides. At present, the conventional vaccine scheme consists of three doses that should be administered at weeks 0, 4 and 7, followed by a booster every six months.
In this study we assayed a reduction in the number of the initial doses of Gavacplus, evaluated the time course and the level of bovine anti-Bm86 antibodies elicited, and analyzed the vaccine effect on ticks engorging on immunized cattle under production conditions. Following three different immunization schemes, the bovines developed a strong and specific immune response characterized by elevated anti-Bm86 IgG titers. A reduction in the weight of engorging female ticks, in the weight of the eggs laid and also in R. microplus viable eggs percentage was obtained by using only two doses of Gavacplus administered at weeks 0 and 4, followed by a booster six months later. This reduction did not differ from the results obtained on ticks engorging on cattle immunized at weeks 0, 4 and 7. It was also demonstrated that anti-Bm86 antibody titers over 1:640, measured in bovines immunized at weeks 0 and 4, were sufficient to affect weight and reproductive potential of female ticks as compared with ticks engorging on unvaccinated animals. In addition, no statistically significant differences were detected in the average weight of eggs laid by ticks engorged on immunized cattle that showed anti-Bm86 specific titers in the range of 1:640 to 1:81920.
The administration of two initial doses of Gavacplus containing 100 μg of Bm86 antigen to non-immunized cattle under production conditions is sufficient to affect the weight and the reproductive capacity of R. microplus engorging females. According to these results, cattle herds' manipulation and vaccine costs could be potentially reduced with a positive impact on the implementation of integrated control programs against R. microplus.
Rhipicephalus microplus is an ectoparasite that currently affects the cattle industry in many regions of the world and it is also an important vector for the transmission of parasites in diseases such as anaplasmosis and babesiosis [1, 2].
The use of acaricides is the most extended prophylactic and therapeutic method to control ectoparasites. However, some relevant drawbacks regarding their use are the development of acaricide-resistant ticks after repeated treatments, the chemical contamination of cattle-derived products and of the environment [3–5]. In the last years, these factors led to the selection of alternative strategies aiming to achieve a better control of ectoparasites under safer approaches [6–8].
Efforts were primarily focused in the identification and characterization of concealed Bm86-like antigens as vaccine candidates [9–13]. Other tick antigens such as BmTI, serine protease inhibitors and 4D8 have been described in recent years with marked potential for the development of novel or combined vaccines [14–17]. However, only two Bm86-based vaccines commercially available have been used in the field in different countries involving the immunization and monitoring of a large number of bovines [18–21]. Nowadays, it is known that using Bm86 for cattle immunization turns into a highly effective control method if it is used as part of an integrated control program in which acaricides are simultaneously applied according to the infestation index detected [21, 22]. The most remarkable benefits regarding the use of Bm86-derived vaccines are the reduction in reproductive capacity of engorging females and in the frequency of acaricide treatments.
The implementation of such programs using Gavacplus implies an immunization scheme that starts with the administration of three doses at weeks 0, 4, and 7, followed by boosters every six months [22–24]. This method showed its effectiveness in the induction of high antibody titers in bovines in spite of their race, sex, or reproductive category . However, this regimen demands an arduous manipulation of cattle herds in the first two months since treatment is performed. Therefore, the implementation of a different schedule that allows a reduction of manipulation and vaccine costs constitutes a desirable fact for both practical and commercial points of view. The Bm86 antigen contained in Gavacplus is obtained in a highly particulated form, with high homogeneity and reproducibility in P. pastoris yeast , under strict controls of a well-recognized biotechnology industry [8, 27]. Taking into consideration that this antigen is immunogenically superior with regard to the monomeric form of the protein , this fact prompted us to investigate the capacity of two doses of the vaccine to elicit immune responses and tick damage similar to those achieved with the use of three inoculations. In this work, we demonstrated that the generation of specific antibodies and the physical damage caused to female ticks engorging on cattle immunized under production conditions remained invariable after reducing in one dose the number of initial administrations of the Gavacplus vaccine.
Immunization experiments in cattle under production conditions
Ten active production farms, located in the same geographical area (22°41'N, 82°53'W) in Candelaria municipality, Pinar del Rio Province (on the Western part of Cuba), were selected for the experiment. These farms are located approximately 0.85 Km separated from each other within an area of about 36 Km2 and have equivalent conditions of humidity, temperature, grass type and indexes from moderate to high of natural infestations with R. microplus. Farms were randomly assigned to each experimental group, and different immunization schemes with the Bm86-based Gavacplus vaccine were assayed. After immunizations took place, a sample of 30% of bovines per farm was selected at random to measure the biological parameters of ticks under engorgement as it will be described below. In all cases, cross-bred (Bos taurus × Bos indicus) non-immunized bovines, with approximately the same age and composition, were used. Manipulation of cattle herds during the immunization trials was similar to all groups and was carried out following the standard procedures for experimentation with animals. The trials and the distribution of animals by farms were done in the following way: Animals in Farm 1 (86 animals), Farm 4 (102 animals) and Farm 7 (192 animals) were immunized at weeks 0, 4 and 7; animals in Farm 2 (106 animals), Farm 6 (161 animals) and Farm 9 (150 animals) were immunized at weeks 0 and 4; animals in Farm 3 (116 animals), Farm 5 (151 animals) and Farm 8 (168 animals) were vaccinated at weeks 0 and 7, while Farm 10 (131 animals) was considered as a control group with unvaccinated animals. Animals were immunized by using a deep intramuscular injection, 21 × 11/2" needles and 2 mL of Gavacplus, containing 100 μg of recombinant Bm86 antigen emulsified in the oil-based adjuvant Montanide 888. Additional booster doses were given to all vaccinated animals six months after they were first immunized.
Serum collection and assessment of anti-Bm86 antibody titers
Blood samples were taken from randomly selected bovines at weeks 0, 4, 7, 12, 16, 20, 24 and 27, in order to study the time course and anti-Bm86 specific antibody levels. These animals (30% of bovines per farm) were also considered for measuring the biological parameters of ticks under engorgement. Serum samples were stored at -20°C until use. Anti-Bm86 IgG titers were determined by ELISA as it was previously described , with minor modifications. Titers from individual animals were expressed as the maximum dilution having an OD492nm higher than two folds the average OD from a bovine seronegative control serum.
Determination of the average weight and reproductive capacity of ticks engorging on vaccinated animals
As the experiment was conducted under production conditions, adult female ticks engorging on vaccinated cattle were collected from a representative number of animals at approximately each time point in which serum samples were also taken (subsequently from weeks 0 to 27). The effects produced by the three schemes of immunization with Gavacplus were evaluated by measuring the following parameters: the average weight of engorging females, the average weight of eggs laid per gram of engorging female (referred as normalized weight of eggs laid that expresses the reproductive capacity of females considering that the eggs laid weight is directly related to the weight of the engorging female), and then the percentage of viable eggs.
For these objectives, adult engorging females were washed with distilled water, dried, and individually weighted. They were immobilized on adhesive tapes and placed into acclimatized chambers at 28°C, 90% of humidity and photoperiods of 12 hours, until oviposition. The number of eggs laid from every single tick was then weighted and loaded in glass flasks with cotton caps. They were kept in similar conditions of temperature and humidity until hatching. The percentage of viable eggs (hatchability) was determined by direct counting of larvae and eggs from each flask sample. The comparison of hatchability between the two time points selected (before starting the immunization trials and after finishing them) was conducted for the three schemes evaluated.
Specific anti-Bm86 antibody titers were determined from a representative number of immunized animals at each farm. Geometric mean titers (GMT) and standard deviations were calculated for all the experimental groups. Differences in anti-Bm86 GMT, in the weight of engorging females, and in normalized weight of eggs laid in each immunized group were determined from weeks 0 to 27 using the non-parametric Friedman's test. These two last parameters measured on ticks when the experiment ended were compared with values obtained prior to immunization using a Mann-Whitney's test, with p < 0.05. The medians of the percentages of viable eggs from ticks engorging on bovines prior to immunization and after vaccination were compared for each scheme by a Kruskal Wallis and a Dunn's test. The statistical software GraphPad Prism v4.0 was used in all cases.
Results and Discussion
Different immunization regimens with Gavacplusinduce a potent response of anti-Bm86 specific antibodies
The level of the immune response obtained with two initial vaccinations of Gavacplus suggested that an effective action could be expected on ticks. Comparisons on the regimens of vaccination and their effects on ticks were conducted in this investigation under standard production conditions. One farm remained with unvaccinated animals and was considered as a negative control.
Two initial doses of Gavacplusaffected the reproductive potential of ticks engorging on immunized cattle
Average weight of engorging female ticks detached from immunized cattle.
Average weight (in mg) of engorging females [95% confidence interval]
Immunizations at 0, 4, 7
Immunizations at 0, 4
Immunizations at 0, 7
186 [125 -285]a
Mean values of normalized weight of eggs laid from ticks engorged on vaccinated animals.
Mean weight (in mg) of eggs laid by individual ticks [confidence interval 95%]
Immunizations at 0, 4, 7
Immunizations at 0, 4
Immunizations at 0, 7
Percentage of eggs that hatched determined from ticks engorged on vaccinated cattle before and after immunizations.
Medians of hatchability (%)
0, 4, 7
Anti-Bm86 antibody titers ranging from 1:640 to 1:81920 induced similar effects on the reproductive capacity of ticks following immunization of cattle at weeks 0 and 4
At present, the Gavacplus vaccine is commercialized in various countries in which it is applied as part of tick control programs that combine the use of acaricide treatments with acquired immunity to Bm86. Its practical value is also preceded by more than fifteen years of research and application in the field. Although further experiments could be added to the results that are here presented, the application of the suggested scheme in the field is currently in progress.
It has been demonstrated that two doses of Gavacplus administered at weeks 0 and 4 to non-immunized cattle under production conditions are sufficient to elicit high anti-Bm86 specific antibodies, which are able to mediate damaging effects on ticks similar to those recorded with the use of three doses. The reduction in the number of inoculations could be a favorable issue when dealing with a large number of bovines as the stress associated with vaccination and manipulation can potentially affect milk and meat production in cattle herds.
The authors would like to thank the helpful assistance of technical personnel involved in the development of the immunization trials.
- Barreira JD: Efeito da infecção de Babesia bovis (Babes, 1988) e Babesia bigemina (Smith & Kilborne, 1893) (Protozoa Babesiidae) sobre os parámetros biológicos do garrapato Boophilus microplus (Canestrini, 1893). Tese Doutorado. 2001, Universidade Federal Rural do Rio de Janeiro, Instituto de Biología, Río de Janeiro, 138-"In Portuguese"Google Scholar
- Peter RJ, Van den Bossche P, Penzhorn BL, Sharp B: Tick, fly, and mosquito control- Lessons from the past, solutions for the future. Vet Parasitol. 2005, 132: 205-215. 10.1016/j.vetpar.2005.07.004.PubMedView ArticleGoogle Scholar
- George JE: Present and future technologies for tick control. Ann N Y Acad Sci. 2000, 916: 583-588. 10.1111/j.1749-6632.2000.tb05340.x.PubMedView ArticleGoogle Scholar
- George JE, Pound JM, Davey RB: Chemical control of ticks on cattle and the resistance of these parasites to acaricides. Parasitol. 2004, 129: 353-366. 10.1017/S0031182003004682.View ArticleGoogle Scholar
- Graf JF, Gogolewski R, Learch-Bing N, Sabatini GA, Molento MB, Bordin EL, Arantes GJ: Tick control: an industry point of view. Parasitol. 2004, 129: 427-442. 10.1017/S0031182004006079.View ArticleGoogle Scholar
- Rodríguez M, Rubiera R, Penichet M, Montesino R, Cremata J, Falcón V, Sánchez G, Bringas R, Cordovés C, Valdéz M, Lleonart R, Herrera L, de la Fuente J: High level expression of the Boophilus microplus Bm86 antigen in the yeast Pichia pastoris forming highly immunogenic particles for cattle. J Biotechnol. 1994, 33: 135-146. 10.1016/0168-1656(94)90106-6.PubMedView ArticleGoogle Scholar
- Cobon G, Hungerford J, Woodrow M, Smith D, Willandsen P: Vaccination against Boophilus microplus: the Australian field experience. Recombinant vaccines for the control of cattle tick. Edited by: de la Fuente J. 1995, Havana, Cuba: Elfos Scientiae, 163-176.Google Scholar
- de la Fuente J, Almazán C, Canales M, Pérez de la Lastra JM, Kocan KM, Willadsen P: A ten-year review of commercial vaccine performance for control of tick infestations on cattle. Anim Health Res Rev. 2007, 8: 23-28. 10.1017/S1466252307001193.PubMedView ArticleGoogle Scholar
- Willadsen P, Kemp DH: Vaccination with concealed antigens for tick control. Parasitol Today. 1988, 4: 196-198. 10.1016/0169-4758(88)90084-1.PubMedView ArticleGoogle Scholar
- Opdebeek JP: Vaccines against blood-sucking arthropods. Vet Parasitol. 1994, 54: 205-222. 10.1016/0304-4017(94)90091-4.View ArticleGoogle Scholar
- Wikel SK: Host immunity to ticks. Annu Rev Entomol. 1996, 41: 1-22. 10.1146/annurev.en.41.010196.000245.PubMedView ArticleGoogle Scholar
- McKenna RV, Riding GA, Jarmey JM, Pearson RD, Willadsen P: Vaccination of cattle against the Boophilus microplus using a mucin-like membrane glycoprotein. Parasite Immunol. 1998, 20: 325-336. 10.1046/j.1365-3024.1998.00149.x.PubMedView ArticleGoogle Scholar
- García-García JC, Montero C, Redondo M, Vargas M, Canales M, Boué O, Rodríguez M, Joglar M, Machado H, González IL, Valdés M, Méndez L, de la Fuente J: Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus. Vaccine. 2000, 18: 2275-2287. 10.1016/S0264-410X(99)00548-4.PubMedView ArticleGoogle Scholar
- Andreotti R, Gomes A, Malavazi-Piza KC, Sasaki SD, Sampaio CAM, Tanaka AS: BmTI antigens induce a bovine protective immune response against Boophilus microplus tick. Int Immunopharmacol. 2002, 2: 557-563. 10.1016/S1567-5769(01)00203-X.PubMedView ArticleGoogle Scholar
- Sasaki SD, Azzolini SS, Hirata IY, Andreotti R, Tanaka AS: Boophilus microplus tick larvae, a rich source of Kunitz type serine proteinase inhibitors. Biochimie. 2004, 86: 643-649. 10.1016/j.biochi.2004.09.010.PubMedView ArticleGoogle Scholar
- Almazán C, Kocan KM, Blouin EF, de la Fuente J: Vaccination with recombinant tick antigens for the control of Ixodes scapularis adult infestations. Vaccine. 2005, 23: 5294-5298. 10.1016/j.vaccine.2005.08.004.PubMedView ArticleGoogle Scholar
- Andreotti R: A synthetic BmTI n-terminal fragment as antigen in bovine immunoprotection against the tick Boophilus microplus in a pen trial. Exp Parasitol. 2007, 116: 66-70. 10.1016/j.exppara.2006.11.009.PubMedView ArticleGoogle Scholar
- Rodríguez M, Penichet ML, Mouris AE, Labarta V, Luaces L, Rubiera R, Cordobés C, Sánchez PA, Ramos E, Soto A, Canales M, Palenzuela D, Triguero A, Lleonart R, Herrera L, de la Fuente J: Control of Boophilus microplus populations in grazing cattle vaccinated with a recombinant Bm86 antigen preparation. Vet Parasitol. 1995, 57: 339-349. 10.1016/0304-4017(94)00678-6.PubMedView ArticleGoogle Scholar
- Rodríguez M, Massard CL, Da Fonseca AH, Ramos NF, Machado H, Labarta V, de la Fuente J: Effect of vaccination with a recombinant Bm86 antigen preparation on natural infestations of Boophilus microplus in grazing dairy and beef pure and cross-bred cattle in Brazil. Vaccine. 1995, 13: 1804-1808. 10.1016/0264-410X(95)00119-L.PubMedView ArticleGoogle Scholar
- Willadsen P: Vaccines, genetics and chemicals in tick control: the Australian experience. Trop Anim Health Prod. 1997, 29: 915-945. 10.1007/BF02632941.View ArticleGoogle Scholar
- de la Fuente J, Rodríguez M, Redondo M, Montero C, García-García JC, Méndez L, Serrano E, Valdéz M, Enríquez A, Canales M, Ramos E, Boué O, Machado H, Lleonart R, de Armas CA, Rey S, Rodríguez JL, Artiles M, García L: Field studies and cost-effectiveness analysis of vaccination with Gavac against the cattle tick Boophilus microplus. Vaccine. 1998, 16: 366-373. 10.1016/S0264-410X(97)00208-9.PubMedView ArticleGoogle Scholar
- Rodríguez M, Méndez L, Valdéz M, Redondo M, Espinosa CM, Vargas M, Cruz RL, Barrios HP, Seoane G, Ramírez ES, Boué O, Vigil JL, Machado H, Nordelo CB, Piñeiro M: Integrated control of Boophilus microplus ticks in Cuba based on vaccination with the anti-tick vaccine Gavac. Exp Appl Acarol. 2004, 34: 375-382.View ArticleGoogle Scholar
- Oliva R, Guevara G, Barreto G, Guevara R, Rodríguez M, Montero C, Redondo M, Machado H, Vargas M, del Risco Y, Hernández G, Mederos J, Alfonso R, Casado E, Rivas N, Álvarez J, Pérez I, Salotén D, Boué O: Efecto de la vacunación con Gavac™en el control de la garrapata Boophilus microplus y de las enfermedades hemoparasitarias asociadas a ésta en condiciones de producción en la provincia Camagüey, Cuba. 2002, --- Either ISSN or Journal title must be supplied.. "In Spanish", [http://www.visionveterinaria.com/09may2002.htm]Google Scholar
- de Moura Souza R, Scatamburlo R, Teixeira MH, dos Reis AJ, Seoane G, Castillo E, Rodríguez M, Machado H, Borroto C, Lleonart R: Empleo exitoso de un programa de control integrado en garrapatas del bovino (Boophilus microplus) en el estado de Río de Janeiro, Brasil. International Congress Biotechnology Havana, Havana, Cuba. Edited by: Arrieta J. 2005, 58-59. "In Spanish"Google Scholar
- Enríquez A, Boué O, Redondo M, Montero C, Machado H, Joglar M, Soto A, Rodríguez M, de la Fuente J: Desarrollo y aplicación en bovinos de la nueva formulación vacunal Gavacplus contra la garrapata Boophilus microplus. Biotecnología Aplicada. 1999, 16: 15-17. "In Spanish"Google Scholar
- Canales M, Enríquez A, Ramos E, Cabrera D, Dandie H, Soto A, Falcón V, Rodríguez M, de la Fuente J: Large-scale production in Pichia pastoris of the recombinant vaccine Gavac™ against cattle tick. Vaccine. 1997, 15: 413-422. 10.1016/S0264-410X(96)00192-2.View ArticleGoogle Scholar
- López E, Silva R, Acevedo B, Buxadó JA, Aguilera A, Herrera L: Taking stock of Cuban biotech. Nature Biotechnol. 2007, 25: 1215-1216. 10.1038/nbt1107-1215.View ArticleGoogle Scholar
- García-García JC, Montero C, Rodríguez M, Soto A, Redondo M, Valdés M, Méndez L, de la Fuente J: Effect of particulation on the immunogenic and protective properties of the recombinant Bm86 antigen expressed in Pichia pastoris. Vaccine. 1998, 16: 374-380. 10.1016/S0264-410X(97)80915-2.PubMedView ArticleGoogle Scholar
- Triguero A, Blanco R, Machado H, Rodríguez M, de la Fuente J: Development of enzyme linked immunosorbent assays to measure Bm86 antigen of Boophilus microplus (cattle tick) and to detect anti-Bm86 antibodies in serum samples. Biotechnol Tech. 1999, 13: 119-125. 10.1023/A:1008906003575.View ArticleGoogle Scholar
- Kemp DH, Pearson RD, Gough JM, Willadsen P: Vaccination against Boophilus microplus: localization of antigens on tick gut cells and their interaction with the host immune system. Exp Appl Acarol. 1989, 7: 43-58. 10.1007/BF01200452.PubMedView ArticleGoogle Scholar
- Redondo M, Fragoso H, Ortiz M, Montero C, Lona J, Medellin JA, Fria R, Hernández V, Franco R, Machado H, Rodríguez M, de la Fuente J: Integrate control of acaricide resistant Boophilus microplus populations on grazing cattle in Mexico using vaccination with Gavac™and amidine treatment. Exp Appl Acarol. 1999, 23: 841-849. 10.1023/A:1015925616490.PubMedView ArticleGoogle Scholar
- Machado H, Santizo C: A rapid immunoassay for the quantification of bovine antibodies against recombinant Boophilus microplus Bm86 antigen. Recombinant vaccines for the control of cattle tick. Edited by: de la Fuente J. Havana, Cuba: Elfos Scientiae, 1995, 103-106.Google Scholar
- Canales M, Almazán C, Naranjo V, Jongejan F, de la Fuente J: Vaccination with recombinant Boophilus annulatus Bm86 ortholog protein, Ba86, protects cattle against B. annulatus and B. microplus infestations. BMC Biotechnol. 2009, 31:9: 29-10.1186/1472-6750-9-29.View ArticleGoogle Scholar
- Perez-Perez D, Bechara GH, Machado RZ, Andrade GM, Del Vecchio RE, Pedroso MS, Hernández MV, Farnós O: Efficacy of the Bm86 antigen against immature instars and adults of the dog tick Rhipicephalus sanguineus (Latreille, 1806) (Acari: Ixodidae). Vet Parasitol. 2010, 167: 321-326. 10.1016/j.vetpar.2009.09.034.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.